Cargando…

Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey

BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, Charles N, Ng, Siew C, Banerjee, Rupa, Steinwurz, Flavio, Shen, Bo, Carbonnel, Franck, Hamid, Saeed, Sood, Ajit, Yamamoto-Furusho, Jesus K, Griffiths, Anne, Benchimol, Eric I, Travis, Simon, Lopes, Susana, Rubin, David T, Kaplan, Gilaad G, Armstrong, David, Gearry, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454666/
https://www.ncbi.nlm.nih.gov/pubmed/32793973
http://dx.doi.org/10.1093/ibd/izaa202
_version_ 1783575518231134208
author Bernstein, Charles N
Ng, Siew C
Banerjee, Rupa
Steinwurz, Flavio
Shen, Bo
Carbonnel, Franck
Hamid, Saeed
Sood, Ajit
Yamamoto-Furusho, Jesus K
Griffiths, Anne
Benchimol, Eric I
Travis, Simon
Lopes, Susana
Rubin, David T
Kaplan, Gilaad G
Armstrong, David
Gearry, Richard
author_facet Bernstein, Charles N
Ng, Siew C
Banerjee, Rupa
Steinwurz, Flavio
Shen, Bo
Carbonnel, Franck
Hamid, Saeed
Sood, Ajit
Yamamoto-Furusho, Jesus K
Griffiths, Anne
Benchimol, Eric I
Travis, Simon
Lopes, Susana
Rubin, David T
Kaplan, Gilaad G
Armstrong, David
Gearry, Richard
author_sort Bernstein, Charles N
collection PubMed
description BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to determine how gastroenterologists around the world were approaching the management of IBD. METHODS: Members of the World Gastroenterology Organization (WGO) IBD Task Force contacted colleagues in countries largely beyond North America and Europe, inviting them to review the WGO website for IBD and COVID-19 introduction, with links to guideline documents, and then to respond to 9 ancillary open-ended management questions. RESULTS: Fifty-two gastroenterologists from 33 countries across 6 continents completed the survey (April 14 to May 16, 2020). They were all adhering for the most part to published guidelines on IBD management in the COVID-19 era. Some differences and reductions in services related to access, and some related to approach within their communities in terms of limiting virus spread. In particular, most gastroenterologists reduced in-person clinics (43 of 52), limited steroid use (47 of 51), limited elective endoscopy (45 of 52), and limited elective surgeries (48 of 51). If a patient was diagnosed with COVID-19, immunomodulatory therapy was mostly held. CONCLUSIONS: In most countries, the COVID-19 pandemic significantly altered the approach to persons with IBD. The few exceptions were mostly based on low burden of COVID-19 in individual communities. Regardless of resources or health care systems, gastroenterologists around the world took a similar approach to the management of IBD.
format Online
Article
Text
id pubmed-7454666
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74546662020-08-31 Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey Bernstein, Charles N Ng, Siew C Banerjee, Rupa Steinwurz, Flavio Shen, Bo Carbonnel, Franck Hamid, Saeed Sood, Ajit Yamamoto-Furusho, Jesus K Griffiths, Anne Benchimol, Eric I Travis, Simon Lopes, Susana Rubin, David T Kaplan, Gilaad G Armstrong, David Gearry, Richard Inflamm Bowel Dis Clinical Research BACKGROUND AND AIMS: Persons with inflammatory bowel disease (IBD) may be particularly vulnerable to COVID-19 either because of their underlying disease or its management. Guidance has been presented on the management of persons with IBD in the time of this pandemic by different groups. We aimed to determine how gastroenterologists around the world were approaching the management of IBD. METHODS: Members of the World Gastroenterology Organization (WGO) IBD Task Force contacted colleagues in countries largely beyond North America and Europe, inviting them to review the WGO website for IBD and COVID-19 introduction, with links to guideline documents, and then to respond to 9 ancillary open-ended management questions. RESULTS: Fifty-two gastroenterologists from 33 countries across 6 continents completed the survey (April 14 to May 16, 2020). They were all adhering for the most part to published guidelines on IBD management in the COVID-19 era. Some differences and reductions in services related to access, and some related to approach within their communities in terms of limiting virus spread. In particular, most gastroenterologists reduced in-person clinics (43 of 52), limited steroid use (47 of 51), limited elective endoscopy (45 of 52), and limited elective surgeries (48 of 51). If a patient was diagnosed with COVID-19, immunomodulatory therapy was mostly held. CONCLUSIONS: In most countries, the COVID-19 pandemic significantly altered the approach to persons with IBD. The few exceptions were mostly based on low burden of COVID-19 in individual communities. Regardless of resources or health care systems, gastroenterologists around the world took a similar approach to the management of IBD. Oxford University Press 2020-08-14 /pmc/articles/PMC7454666/ /pubmed/32793973 http://dx.doi.org/10.1093/ibd/izaa202 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://academic.oup.com/pages/standard-publication-reuse-rightsThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
spellingShingle Clinical Research
Bernstein, Charles N
Ng, Siew C
Banerjee, Rupa
Steinwurz, Flavio
Shen, Bo
Carbonnel, Franck
Hamid, Saeed
Sood, Ajit
Yamamoto-Furusho, Jesus K
Griffiths, Anne
Benchimol, Eric I
Travis, Simon
Lopes, Susana
Rubin, David T
Kaplan, Gilaad G
Armstrong, David
Gearry, Richard
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title_full Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title_fullStr Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title_full_unstemmed Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title_short Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
title_sort worldwide management of inflammatory bowel disease during the covid-19 pandemic: an international survey
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454666/
https://www.ncbi.nlm.nih.gov/pubmed/32793973
http://dx.doi.org/10.1093/ibd/izaa202
work_keys_str_mv AT bernsteincharlesn worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT ngsiewc worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT banerjeerupa worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT steinwurzflavio worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT shenbo worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT carbonnelfranck worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT hamidsaeed worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT soodajit worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT yamamotofurushojesusk worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT griffithsanne worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT benchimolerici worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT travissimon worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT lopessusana worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT rubindavidt worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT kaplangilaadg worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT armstrongdavid worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT gearryrichard worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey
AT worldwidemanagementofinflammatoryboweldiseaseduringthecovid19pandemicaninternationalsurvey